
|Articles|August 8, 2008
E-Separation Solutions
- E-Separation Solutions-08-07-2008
- Volume 0
- Issue 0
Determining Distribution of Erlotinib in Pancreatic Tumors by MALDI Using an LTQ Linear Ion Trap
Imaging Mass Spectrometry (IMS) using matrix-assisted laser desorption ionization (MALDI) is being investigated using a linear ion trap with the overall goal of analyzing the distribution of various targeted therapies within patients' tumors.
Advertisement
Articles in this issue
almost 18 years ago
Market Profile: Mass Spectrometry in North America and Europealmost 18 years ago
From the Editor: PharmSep Comes to Philadelphiaalmost 18 years ago
Overcoming Compound Volatility with Sub-ambient ELSDalmost 18 years ago
Technology Forum: Softwarealmost 18 years ago
Ask the Editor: The Effect of Sample Diluent Ionic StrengthAdvertisement
Advertisement
Advertisement
Trending on LCGC International
1
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
2
A Look at the Major Technical Themes of ASMS 2026
3
Mass Spectrometry Approaches for Investigating Alpha-Synuclein Structural Changes in Neurodegenerative Disease
4
LC-MS Links Gut Metabolites to Anxiety Therapy
5




